课题基金 / 基金详情

IN VITRO SCREENING OF POTENTIAL CHEMOPREVENTIVE AGENTS

IN VITRO SCREENING OF POTENTIAL CHEMOPREVENTIVE AGENTS
潜在化学预防剂的体外筛选
批准号:
6096052
负责人:
ANN R KENNEDY
金额:
$18.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
未结题
起止时间:
1999-06-30 至

项目摘要

项目成果

ANN R KENNEDY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Initial growth inhibition assays with the test chemopreventive agent are being used to select appropriate concentration ranges for use in the subsequent transformation-inhibition assay. Five log dilutions from 1 mM or the highest soluble concentration in medium or in a solvent such as dimethylsulfoxide without solvent toxicity. Primary prostate epithelial cells shall be seeded into 60 mm dishes and allowed to attach for 24 hours. Then the chemopreventive test agent shall be added in fresh medium and the cultures allowed to incubate 72 hours then all cultures shall receive fresh media containing only the chemopreventive agent and incubated for 3-5 more days. A positive control compound such as a retinoid shall be used in all assays. Then the cultures shall be fixed and stained. Three dishes per point shall be scored and the relative growth determined. The induction of apoptosis in human prostate epithelial cells is being determined. Methodology to quantitatively measure the level of induction of apoptosis in response to exposure to potential chemopreventive agents is being determined. Five nontoxic concentrations are being measured for their ability to induce apoptosis for each agent. A prostate specific antigen assay to quantitatively measure effects of chemopreventive agents on the production of PSA in cultures of human prostate epithelial cells is being perfromed. At least 5 nontoxic concentrations are being tested for each compound.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
In vitro evaluation of chemopreventive agents using cultured human prostate epithelial cells.
使用培养的人前列腺上皮细胞对化学预防剂进行体外评估。
DOI: --
发表时间: 2003
期刊: Oncology reports
影响因子: 4.2
作者: [Wan,XSteven, Zhou,Zhoazong, Kennedy,AnnR, Kopelovich,Levy]
通讯作者: Kopelovich,Levy
Establishment and characterization of sublines of LNCaP human prostate cancer cells.
LNCaP 人前列腺癌细胞亚系的建立和表征。
DOI: --
发表时间: 2003
期刊: Oncology reports
影响因子: 4.2
作者: [Wan,XSteven, Zhou,Zhaozong, Steele,Vernon, Kopelovich,Levy, Kennedy,AnnR]
通讯作者: Kennedy,AnnR
LATE STAGE CARCINOGENESIS IN VITRO
  • 批准号:
    6362666
  • 项目类别:
  • 资助金额:
    $21.2万
  • 财政年份:
    2000
  • 负责人:
    ANN R KENNEDY
  • 依托单位:
LATE STAGE CARCINOGENESIS IN VITRO
  • 批准号:
    6513283
  • 项目类别:
  • 资助金额:
    $21.72万
  • 财政年份:
    2000
  • 负责人:
    ANN R KENNEDY
  • 依托单位:
LATE STAGE CARCINOGENESIS IN VITRO
  • 批准号:
    6046193
  • 项目类别:
  • 资助金额:
    $20.7万
  • 财政年份:
    2000
  • 负责人:
    ANN R KENNEDY
  • 依托单位:
DEVELOPMENT OF A NEW PSA ASSAY FOR PROSTATE DISEASE
  • 批准号:
    2863387
  • 项目类别:
  • 资助金额:
    $9.91万
  • 财政年份:
    1999
  • 负责人:
    ANN R KENNEDY
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: